• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床分离细菌对抗菌药物的敏感性。一项主要聚焦于亚胺培南的研究。临床分离株亚胺培南敏感性检测研究组

[Susceptibilities of clinical bacterial isolates to antimicrobial agents. A study mainly focused on imipenem. Research Group for Testing Imipenem Susceptibility on Clinical Isolates].

作者信息

Igari J

机构信息

Department of Clinical Pathology, School of Health Sciences, Faculty of Medicine, University of the Ryukyus.

出版信息

Jpn J Antibiot. 1990 Oct;43(10):1723-82.

PMID:2086814
Abstract

We investigated susceptibilities of clinical bacterial isolates to imipenem (IPM) and other antimicrobial agents at 459 hospital laboratories throughout Japan from September to December of 1988. In this study, identification and susceptibility testing were performed at each hospital laboratory and the tests were carried out according to the 1-dilution or 3-dilution disc technique in which susceptibilities are classified into 4 grades: , ++, + and -. IPM had significantly high activity against Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae, Neisseria gonorrhoeae, Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter aerogenes, Enterobacter cloacae, Salmonella spp., Citrobacter freundii, Proteus mirabilis, Providencia rettgeri, Acinetobacter calcoaceticus, Moraxella catarrhalis, Alcaligenes spp., Peptococcus spp./Peptostreptococcus spp., Bacteroides fragilis and Bacteroides spp. and should slightly lower activities on coagulase-negative staphylococci (CNS), Enterococcus faecalis, Haemophilus influenzae, Serratia marcescens, Proteus vulgaris, Providencia stuartii and Pseudomonas aeruginosa than on the above mentioned bacteria. In a comparative study on activities of IPM against bacteria from different clinical sources, no remarkable differences were found due to different sources among S. pneumoniae, E. faecalis, H. influenzae, E. coli, K. pneumoniae, E. cloacae, C. freundii, P. mirabilis or A. calcoaceticus, whereas slight differences were found among Staphylococcus aureus, CNS, S. marcescens and P. aeruginosa.

摘要

1988年9月至12月期间,我们在日本全国459家医院实验室调查了临床分离细菌对亚胺培南(IPM)及其他抗菌药物的敏感性。在本研究中,各医院实验室进行了细菌鉴定和药敏试验,试验采用1倍稀释或3倍稀释纸片法,药敏结果分为4级: 、++、+和 - 。IPM对肺炎链球菌、化脓性链球菌、无乳链球菌、淋病奈瑟菌、大肠埃希菌、肺炎克雷伯菌、产酸克雷伯菌、产气肠杆菌、阴沟肠杆菌、沙门菌属、弗劳地枸橼酸菌、奇异变形杆菌、雷氏普罗威登斯菌、醋酸钙不动杆菌、卡他莫拉菌、嗜碱杆菌属、消化球菌属/消化链球菌属、脆弱拟杆菌及其他拟杆菌属具有显著的高活性,而对凝固酶阴性葡萄球菌(CNS)、粪肠球菌、流感嗜血杆菌、黏质沙雷菌、普通变形杆菌、斯氏普罗威登斯菌和铜绿假单胞菌的活性略低于上述细菌。在一项关于IPM对不同临床来源细菌活性的比较研究中,肺炎链球菌、粪肠球菌、流感嗜血杆菌、大肠埃希菌、肺炎克雷伯菌、阴沟肠杆菌、弗劳地枸橼酸菌、奇异变形杆菌或醋酸钙不动杆菌因来源不同未发现显著差异,而金黄色葡萄球菌、CNS、黏质沙雷菌和铜绿假单胞菌之间存在细微差异。

相似文献

1
[Susceptibilities of clinical bacterial isolates to antimicrobial agents. A study mainly focused on imipenem. Research Group for Testing Imipenem Susceptibility on Clinical Isolates].临床分离细菌对抗菌药物的敏感性。一项主要聚焦于亚胺培南的研究。临床分离株亚胺培南敏感性检测研究组
Jpn J Antibiot. 1990 Oct;43(10):1723-82.
2
[Susceptibilities of clinical bacterial isolates to antimicrobial agents. A study mainly focused on imipenem. Reported by the Research Group for Testing Imipenem Susceptibility on Clinical Isolates].临床分离细菌对抗菌药物的敏感性。一项主要聚焦于亚胺培南的研究。临床分离株亚胺培南敏感性检测研究组报告
Jpn J Antibiot. 1990 Nov;43(11):1956-2002.
3
[Susceptibilities of clinical bacterial isolates to antimicrobial agents, 1989. A study mainly focused on imipenem. The Research Group for Testing Imipenem Susceptibilities of Clinical Isolates].
Jpn J Antibiot. 1991 Dec;44(12):1329-40.
4
[A nationwide survey of antimicrobial susceptibilities of clinical isolates to antibiotics in Japan (1988-1990)].[日本全国范围内临床分离株对抗生素的药敏调查(1988 - 1990年)]
Jpn J Antibiot. 1993 Jun;46(6):454-71.
5
[Susceptibilities of clinical isolates to antibacterial agents. A study mainly focused on ofloxacin (the second report). Reported by the Research Group for Testing ofloxacin Susceptibility on Clinical Isolates].临床分离株对抗菌药物的敏感性。一项主要聚焦于氧氟沙星的研究(第二篇报告)。临床分离株氧氟沙星敏感性检测研究组报告
Jpn J Antibiot. 1989 May;42(5):1125-65.
6
[Antimicrobial activity of cefodizime against clinical isolates].头孢地嗪对临床分离株的抗菌活性
Jpn J Antibiot. 1996 Oct;49(10):947-65.
7
[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].头孢唑肟对各种临床分离株抗菌活性的上市后监测——II. 革兰氏阴性菌
Jpn J Antibiot. 2002 Feb;55(1):22-60.
8
[Nationwide survey on susceptibilities of clinical isolates to antibacterial agents in 1991].
Jpn J Antibiot. 1995 Mar;48(3):409-20.
9
[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].头孢唑兰对各种临床分离株抗菌活性的上市后监测——II. 革兰氏阴性菌
Jpn J Antibiot. 2003 Oct;56(5):458-96.
10
[Antibacterial activities of monobactams against fresh clinical isolates].单环β-内酰胺类抗生素对临床新鲜分离株的抗菌活性
Jpn J Antibiot. 1988 Nov;41(11):1600-22.